EichorEICHOR
Condition: Other Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Other

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · 90 location(s) · Pfizer · NCT05020236Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · 10 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183Clozapine-related Immunodeficiency in Parkinsons Disease
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06634641Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Phase 2 · 13 location(s) · Gates Medical Research Institute · NCT07525427RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05704582Brain Imaging of Cognition Inn Schizophrenia and Depression
Phase N/A · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT04159662Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
Phase 2 · 2 location(s) · Samsung Medical Center · NCT04591002Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome
Phase N/A · 1 location(s) · Abant Izzet Baysal University · NCT07411222The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
NA · 1 location(s) · Massachusetts General Hospital · NCT06386588A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumor
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06469008A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumor
Phase 2 · 1 location(s) · Minghui Pharmaceutical (Hangzhou) Ltd · NCT07130383Cerebellar Stimulation and Cognitive Control
NA · 1 location(s) · Krystal Parker, PhD · NCT03217110NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
Phase 2 · 1 location(s) · China Medical University Hospital · NCT06021197Screening for Malnutrition in Obese Patients
Phase N/A · 3 location(s) · HAN University of Applied Sciences · NCT06626360A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Phase 1 · 2 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05470348Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or B
NA · 2 location(s) · Vestre Viken Hospital Trust · NCT06197048Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01441089Effect of Immediate Placement and Loading of Compressive Versus Conventional Implants
NA · 1 location(s) · Ahmed Nagi Alghandour · NCT07601347A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · 95 location(s) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404BREATHE Free: a Pilot Feasibility Trial
NA · 1 location(s) · Augusta University · NCT06862050Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Phase 1/Phase 2 · 9 location(s) · Revolution Medicines, Inc. · NCT07397338Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Phase 2 · 16 location(s) · Novartis Pharmaceuticals · NCT07467993Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: RO
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT01639508A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · 39 location(s) · Bristol-Myers Squibb · NCT07288567Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostat
Phase 2 · 3 location(s) · Martha Mims · NCT03833921How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
NA · 1 location(s) · Geisinger Clinic · NCT06495021A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · 85 location(s) · GlaxoSmithKline · NCT06885034A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · 22 location(s) · Neurocrine Biosciences · NCT07105111Magnetic Seizure Therapy for Schizophrenia - Trial
NA · 2 location(s) · Centre for Addiction and Mental Health · NCT06672588Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging In
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01200953
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.